SCHEMBL5635947

SCHEMBL5635947

CCCCOC(=O)n1ccc2cccc(C)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.45
OXER1 Q8TDS5 1/20 0.41
TSHR P16473 7/20 0.41
TDP1 Q9NUW8 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ESR1 P03372 2/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 3/20 0.37
CYP3A4 P08684 3/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
TP53 P04637 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30109225 0.89 KMT2A (0.42) BCHETSHRTDP1L3MBTL1KMT2A
SCHEMBL2117227 0.89 KMT2A (0.42) BCHETSHRTDP1L3MBTL1KMT2A
SCHEMBL5635573 0.79 NOTUM (0.53) BCHETSHRTDP1L3MBTL1KMT2A
SCHEMBL7165911 0.78 NPC1 (0.45) TDP1L3MBTL1KMT2AMEN1MAPK1
SCHEMBL18714661 0.78 BCHE (0.45) BCHETSHRTDP1L3MBTL1ESR1
SCHEMBL30109124 0.78 NOTUM (0.39) BCHETSHRL3MBTL1KMT2AMEN1
SCHEMBL4167876 0.78 NOTUM (0.39) BCHETSHRL3MBTL1KMT2AMEN1
SCHEMBL2117213 0.76 CA12 (0.49) BCHEKMT2AMAPK1CNR2TP53
SCHEMBL31549612 0.75 ESR1 (0.49) BCHETSHRTDP1L3MBTL1ESR1
SCHEMBL30711258 0.74 ACLY (0.47) BCHEL3MBTL1KMT2ANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US disclosed
EP-1689710-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2006-08-16 EP disclosed
WO-2005051908-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010559-A1 Indole derivatives for use as chemical uncoupler GPR119, IDO2, IDO1 BCHE 2543/4885OXER1 470/4885TSHR 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.